Living With Gout? Consider Joining a Clinical Trial.

Join the RUBY Study of a possible treatment for adults with gout who still have flare-ups despite taking allopurinol. The RUBY Study will test how effective and safe a study drug called dotinurad may be in treating gout, compared to allopurinol.

You may be able to join the RUBY Study if you:

Are 18 to 75 years old

Have been diagnosed with gout for at least 1 year

Have had at least 2 gout flares in the last 12 months before joining the study

Have been taking the same dose of allopurinol for at least 3 months

If you qualify, you may receive at no cost:

Either dotinurad or study-supplied allopurinol

Monitoring by the study team throughout the study

Reimbursement for reasonable study-related expenses (travel and meals)

You can make a difference!

Date of Birth (mm/dd/yyyy)

By signing up you agree to receive text messages and emails about this and similar studies near you. You can unsubscribe at any time. Text messages and data rates may apply. You also agree that StudyKIK may provide your personal information to the sponsor of this study or the research site to help determine if you qualify for this study. Please refer to StudyKIK's Privacy Policy and Terms of Service for more information.